SCHEMBL5373746

SCHEMBL5373746

Cc1cc(C#N)cc(Oc2cc(Cc3ccc(=O)[nH]n3)ccc2C)c1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.42
CYP3A4 P08684 4/20 0.41
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
VEGFA P15692 2/20 0.36
THRA P10827 2/20 0.33
THRB P10828 2/20 0.33
EPAS1 Q99814 1/20 0.31
IDH1 O75874 1/20 0.31
MGLL Q99685 1/20 0.31
XDH P47989 1/20 0.31
LRRK2 Q5S007 1/20 0.31
CARM1 Q86X55 1/20 0.30
PRMT6 Q96LA8 1/20 0.30
SLC22A12 Q96S37 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14570721 0.95 CYP3A4 (0.41) KCNH2CYP3A4CYP2C9CYP2C19THRA
SCHEMBL5385784 0.90 CYP3A4 (0.44) KCNH2CYP3A4CYP2C9CYP2C19VEGFA
SCHEMBL14570708 0.90 KCNH2 (0.45) KCNH2CYP3A4CYP2C9CYP2C19VEGFA
SCHEMBL5386025 0.90 CYP3A4 (0.48) KCNH2CYP3A4CYP2C9CYP2C19VEGFA
SCHEMBL5377332 0.90 CYP3A4 (0.49) CYP3A4CYP2C9CYP2C19VEGFAEPAS1
SCHEMBL5375295 0.88 CYP3A4 (0.47) CYP3A4CYP2C9CYP2C19EPAS1IDH1
SCHEMBL5377805 0.82 CYP3A4 (0.45) KCNH2CYP3A4CYP2C9CYP2C19
SCHEMBL5371174 0.82 CYP3A4 (0.51) CYP3A4THRATHRBSLC22A12
SCHEMBL14559753 0.81 AR (0.39) KCNH2CYP3A4CYP2C9CYP2C19SLC22A12
SCHEMBL5370985 0.80 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 US disclosed
US-7189718-B2 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC (US) 2007-03-13 US disclosed